Table 2 List of analysed variables on drug-related harm reduction interventions and its policy framework

Screening of people in prison for drug-related problems upon entry

HIV testing available

Responsible institution for prison health/prison structure

OST available

HIV testing rate (%) among people in prison last year

external agencies (incl. NGOs) included in harm reduction service provision

OST coverage 1.—% of prisons where available

HIV testing coverage (last year) estimated if rate cannot be calculated

Strategy document for drug-related responses in prison available

OST coverage 2. % of people in prison in need receive OST

HCV testing available

Guidelines/strategy for drug-related responses in prison where

Number of inmates receiving OST

HCV testing rate (%) among people in prison last year

Guidelines/strategy for harm reduction in prison available

Dominant type of OST medication provided in prisons

HCV testing coverage (last year) estimated if rate cannot be calculated

Guidelines/strategy for harm reduction in prison where

OST Detoxification available

HBV testing available

Guidelines/strategy for testing/treatment of infectious diseases in prison available

OST continued for people in prison already in OST before entering prison available

HBV testing rate (%) among people in prison last year

Guidelines/strategy for testing/treatment of infectious diseases in prison where

OST initiated after entering prison available

HBV testing coverage (last year) estimated if rate cannot be calculated

Guidelines/strategy for harm reduction measures upon release available

OST initiated before release available

TB testing available

Guidelines/strategy for harm reduction measures upon release where

NSP available

TB testing estimated coverage last year

Equivalence of care

NSP coverage 1.—% of prisons where available

Vaccination for HBV available

Continuity of care

NSP coverage 2.—% of people in prison in need receive NSP

HIV post-exposure prophylaxis available

Distribution of bleach available

Antiretroviral therapy for HIV available

Estimated coverage of bleach distribution: % of prisons where available

Antiretroviral therapy for HIV estimated coverage

Condom provision available

Antiviral therapy for HCV available

Estimated coverage of condom promotion and distribution programmes in prisons, % of prisons where it is provided

Antiviral therapy for HCV estimated coverage

Lubricants provision available

Antiviral therapy for HBV available

Information and education on drug-related health risks (in general) available

Antiviral therapy for HBV estimated coverage

Health education to prevent overdoses during imprisonment available

TB treatment available

Health education (as prevention) on drug-related infectious diseases available

TB treatment coverage

Health education on drug-related infectious diseases coverage: % of people in prison receive it

Linkage to HIV care upon release

Health education (as prevention) on sexually transmitted diseases available

Linkage to HCV care upon release

HIV-related health promotion or behaviour change programmes in prisons coverage

Information and education on risks of tattooing and piercing available

Training on safer injecting available

Harm reduction/addiction service provided to people in prison with drug problem upon release available

Health education to prevent overdoses upon release available

Distribution of naloxone upon release available